zostavax [ zoster vaccine live (oka/merck), msd]
merck sharp & dohme (malaysia) sdn bhd - zoster vaccine live oka/merck -
varivax
merck sharp & dohme (new zealand) limited - varicella vaccine 1350 pfu (oka/merck); - injection with diluent - 1350 pfu - active: varicella vaccine 1350 pfu (oka/merck) excipient: dibasic sodium phosphate dodecahydrate gelatin monobasic potassium phosphate monosodium glutamate potassium chloride sodium chloride sucrose urea water for injection - varivax is indicated for vaccination against varicella in individuals 12 months of age and older.
zostavax (zoster vaccine live)
merck sharp & dohme (israel - 1996) company ltd, israel - live attenuated oka/merck strain of varicella-zoster virus - powder and solvent for suspension for injection - live attenuated oka/merck strain of varicella-zoster virus 19400 pfu / 0.65 ml - zoster, live attenuated - zoster, live attenuated - zostavax is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.
varivax powder for solution
merck frosst canada & cie, merck frosst canada & co. - varicella-zoster virus vaccine live attenuated (oka/merck strain) - powder for solution - 1350unit - varicella-zoster virus vaccine live attenuated (oka/merck strain) 1350unit - vaccines
varivax ii powder for solution
merck frosst canada & cie, merck frosst canada & co. - varicella-zoster virus vaccine live attenuated (oka/merck strain) - powder for solution - 1350unit - varicella-zoster virus vaccine live attenuated (oka/merck strain) 1350unit - vaccines
vioxx tab 12.5mg tablet
merck frosst canada & cie, merck frosst canada & co. - rofecoxib - tablet - 12.5mg - rofecoxib 12.5mg - cyclooxygenase-2 (cox-2) inhibitors
vioxx tab 25mg tablet
merck frosst canada & cie, merck frosst canada & co. - rofecoxib - tablet - 25mg - rofecoxib 25mg - cyclooxygenase-2 (cox-2) inhibitors
vioxx suspension 12.5mg/5ml
merck frosst canada & cie, merck frosst canada & co. - rofecoxib - suspension - 12.5mg - rofecoxib 12.5mg - cyclooxygenase-2 (cox-2) inhibitors
proquad
merck sharp & dohme (new zealand) limited - measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)); mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)); rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ); varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose)); - injection with diluent - 0.5 ml - active: measles vaccine 1000 tcid50 (edmonston b strain (3 log per dose)) mumps virus, jeryl-lynn strain 19952 tcid50 (b level (4.3 log per dose)) rubella virus, wistar ra27/3 strain 1000 tcid50 ((3 log per dose) ) varicella vaccine 9772 pfu (oka/merck strain (3.99 log per dose)) excipient: dibasic potassium phosphate dibasic sodium phosphate gelatin minimum essential medium eagle medium 199 monosodium glutamate phenolsulfonphthalein potassium chloride sodium bicarbonate sodium chloride sorbitol sucrose urea water for injection - proquad is indicated for vaccination against measles, mumps, rubella, and varicella in individuals 12 months through 12 years of age.
zostavax
merck sharp & dohme (new zealand) limited - varicella-zoster virus, oka/merck strain, live, attenuated 19400 pfu; - injection with diluent - 19400 pfu - active: varicella-zoster virus, oka/merck strain, live, attenuated 19400 pfu excipient: dibasic sodium phosphate monohydrate gelatin monobasic potassium phosphate monosodium glutamate potassium chloride sodium chloride sucrose urea water for injection - zostavax is indicated for: · prevention of herpes zoster (shingles)